ABSTRACT Erdheim-Chester disease is an unusual syndrome characterized by non-Langerhans cell histiocytosis which can mimic rheumatologic diseases. We report a case of Erdheim-Chester masquerading as giant cell arteritis, which was success-fully managed with anakinra as anti IL-1 therapy.
Cite this paper
J. Skalski, W. Edwards and E. Matteson, "Erdheim-Chester Disease with Right Atrial Tumor and “Temporal Arteritis”," Open Journal of Rheumatology and Autoimmune Diseases, Vol. 2 No. 3, 2012, pp. 37-38. doi: 10.4236/ojra.2012.23008.
 J. Haroche, L. Arnaud and Z. Amoura, “Erdheim-Chester Disease,” Current Opinion in Rheumatology, Vol. 14, No. 1, 2012, pp. 53-59.
 A. Aouba, S. Georgin-Lavialle, C. Pagnoux, N. M. Silva, A. Renand, et al., “Rationale and Efficacy of Interleukin-1 Targeting in Erdheim-Chester Disease,” Blood, Vol. 116, No. 20, 2012, pp. 4070-4076.
 W. Chester, “über Lipoidgranulomatose,” Virchows Archive, Vol. 279, No. 2, 1930, pp. 561-602.
 J. Haroche, P. Cluzel, D. Toledano, G. Montalescot, D. Touitou, et al., “Cardiac Involvement in Erdheim-Chester Disease: Magnetic Resonance and Computed Tomographic Scan Imaging in a Monocentric Series of 37 Patients,” Circulation, Vol. 119, No. 25, 2009, pp. e597-e598. doi:10.1161/CIRCULATIONAHA.108.825075
 E. C. Derrett-Smith and B. Dasgupta, “Erdheim-Chester Disease: Yet another Mimic of Polymyalgia Rheumatica and Giant Cell Arteritis?” Rheumatology, Vol. 44, No. 3, 2005, pp. iii14-iii15.